Application 208443
- Type
- ANDA
- Sponsor
- ACTAVIS LABS FL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FIDAXOMICIN | FIDAXOMICIN | TABLET;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208443-001 | FIDAXOMICIN | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208443-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | 2024-01-16 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | 1c564ffb4f44… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208443-001 | FIDAXOMICIN | 200MG | TABLET / ORAL | AB | 2024-01-16 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A208443-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A208443-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A208443-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208443-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208443-001 | AB | 1 | 6a471c1ec25d… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208443-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208443-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A208443-001 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208443-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A208443-001 | AB | 1 | 1c564ffb4f44… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208443-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fidaxomicin | FIDAXOMICIN | Sandoz Inc | 5e8ad2f1-a227-4171-9b66-cd6ce49b8baa | 2026-05-22 | Warnings, Adverse reactions | Fidaxomicin FIDAXOMICIN |
| Fidaxomicin | FIDAXOMICIN | Apotex Corp. | 6cc3e803-8935-f9b3-ab7f-fef8b1c02070 | 2026-02-13 | Warnings, Adverse reactions | Fidaxomicin FIDAXOMICIN |
| Fidaxomicin | FIDAXOMICIN | Torrent Pharmaceuticals Limited | 8f68f0cb-9573-4d5a-8f31-a93dd2706691 | 2026-01-28 | Warnings, Adverse reactions | Fidaxomicin FIDAXOMICIN |
| Dificid | FIDAXOMICIN | Merck Sharp & Dohme LLC | dd966338-c820-4270-b704-09ef75fa3ceb | 2024-10-16 | Warnings, Adverse reactions | FIDAXOMICIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77487 | ORIG | 2024-02-14 |